Discontinuation report PMS-RABEPRAZOLE EC
| Report ID | 38830 |
| Drug Identification Number | 02310805 |
| Brand name | PMS-RABEPRAZOLE EC |
| Common or Proper name | RABEPRAZOLE |
| Company Name | PHARMASCIENCE INC |
| Market Status | DORMANT |
| Active Ingredient(s) | RABEPRAZOLE SODIUM |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2018-02-02 |
| Remaining supply date | 2018-02-02 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | IN PROCESS FOR DEACTIVATION |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2018-02-06 | French | Compare |
| v1 | 2018-02-06 | English | Compare |
Showing 1 to 2 of 2